Supplemental Methods
SNP Analysis
Genomic DNA from six CMS affected individuals and eight of their family members was isolated from whole blood and sent to The Centre for Applied Genomics, (The Hospital for Sick Children, Toronto, Canada) for SNP genotyping (250K NspI array). Affymetrix (Affymetrix Inc., Santa Clara, California, USA) Genotyping console software (version 4.1) was used to analyze SNP data. The allele call rate ranged from 94.66 -98.91%.
Preparation and Sequencing of Agilent All-Exome Capture Library
For whole exome sequencing, genomic DNA was quantified using a Quant-iT dsDNA HS assay kit and a Qubit fluorometer (Invitrogen). Approximately 500ng of DNA was sheared for 75 seconds at duty cycle "20%" and intensity of "5" using a Covaris E210, and run on an 8% PAGE gel. A 200-500 bp DNA fraction was excised and eluted from the gel slice, and was ligated to Illumina paired-end adapters following a standard protocol as described previously 1 .
The adapter ligated DNA was amplified for 10 cycles using the PE primer set (Illumina) and purified as a pre-exome capture library DNA. The DNA was assessed using an Agilent DNA 1000 Series II assay, and the 500ng library DNA was hybridized to the 50Mb exon probe using the Human All exon Kit (Cat#G3370) following the SureSelect Human All exon 50 Mb Target Enrichment kit protocol. The capture DNA was purified using a Qiagen (QIAGEN Sciences, Maryland, USA) MiniElute column, and amplified for 12 cycles using the standard Illumina PE primer set. The PCR products were run of an 8% PAGE gel, the desired size range (320 -370 bp) was excised and purified, and was then assessed using an Agilent DNA 1000 series II assay and diluted to 10nM. The final library DNA concentration was confirmed using a Quanti-iT dsDNA HS assay kit and Qubit fluorometer for cluster generation and sequencing.
Bioinformatic Analysis
All samples were sequenced on Illumina HiSeq-2000 platforms following the manufacturer's recommendations. Chastity-passed reads were mapped to the reference human genome (hg18) using Burrows-Wheeler algorithm 0.5.7 2 . Duplicate reads were removed prior to SNV calling; duplicate reads and reads having mapping quality of 0 were removed prior to small indel calling.
The aligned reads were exported to pileup format and variants were called using SAMtools 0.1.13 3 . Single nucleotide variants (SNVs) were filtered, using SAMtools.pl varFilter (all default parameters, except -D 1000), retaining SNVs with a minimum SNP quality of 20 (awk '$6>=20'). Small indels were processed similarly using SAMtools varFilter default parameters, except -D 1000, -d2 and -1 1.
All SNVs and small indels were imported into a local PostgreSQL database used to store and process human variation data 4 . Ensembl 54 annotations were used to identify variations that cause non-synonymous changes in protein-coding regions and those that fall within two bases of exon boundaries (which, potentially interfere with intron splicing). Using the database API, common polymorphisms were filtered out by their presence in dbSNP129/130 5 , genomes sequenced as part of the 1000 Genomes Project 6 , and other genomes sequences at the BC Genome Sciences Centre, or gathered from public sources. This filtering procedure led to a tractable number of candidate disease-causing mutations in each study subject (Table S1 ).
DNA Sequencing
Intronic primers flanking the identified mutations (from whole exome sequencing) in GPSM2 were designed using ExonPrimer (Institute of Human Genetics, Munich, Germany).
The sequence of the forward and reverse primers, the annealing temperatures and sizes of the amplified products is given in Table S2 . 100ng of genomic DNA was used in each amplification reaction. All PCR reactions started with a 3 min denaturation step at 95°C, followed by 30 cycles of 1 min at 95°C, 1 min at the calculated annealing temperature, and 2 min at 72°C. At the end of the 30 cycles, a 10 min extension at 72°C was performed. The PCR products were separated by agarose gel electrophoresis, and the DNA fragments purified using a Qiagen 
GPSM2 Transcript Analysis
Total mRNA was isolated from lymphoblastoid cell lines using the RNeasy Mini Kit (QIAgen, Valencia, CA), and polyA cDNA was generated using the RevertAid cDNA Synthesis kit (Fermentas Life Sciences, Glen Burnie, MD). To detect changes in exon 9 splicing, we performed RT-PCRs under standard conditions using forward primers in exons 8 and 9, and a reverse primer in exon 10. Primer sequences and conditions are listed in Table S2 .
Supplemental Web Resources
Basic Local Alignment Search Tool, http://blast.ncbi.nlm.nih.gov -TTA TGG CTG TAA GCT TCC CTA C-3 
